TRCT
GOCO

Tower Research Capital (TRC)’s GoHealth GOCO Stock Holding History

Tower Research Capital (TRC)’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,352
Closed -$9.59K – 5399
2026
Q1 		$9.59K Buy
6,352
+5,469
+619% +$10.4K ﹤0.01% 3922
2025
Q4 		$1.9K Sell
883
-2,450
-74% -$8.37K ﹤0.01% 4618
2025
Q3 		$16.1K Buy
3,333
+929
+39% +$5.07K ﹤0.01% 3500
2025
Q2 		$13.3K Buy
2,404
+1,002
+71% +$7.92K ﹤0.01% 3865
2025
Q1 		$17.2K Buy
1,402
+456
+48% +$6.96K ﹤0.01% 3119
2024
Q4 		$12.7K Buy
946
+284
+43% +$3.23K ﹤0.01% 3594
2024
Q3 		$6.21K Sell
662
-2,080
-76% -$21.1K ﹤0.01% 4166
2024
Q2 		$26.7K Buy
2,742
+1,916
+232% +$19K ﹤0.01% 3572
2024
Q1 		$8.68K Sell
826
-162
-16% -$2K ﹤0.01% 3979
2023
Q4 		$13.2K Buy
988
+94
+11% +$1.29K ﹤0.01% 3978
2023
Q3 		$13K Sell
894
-867
-49% -$14.9K ﹤0.01% 3844
2023
Q2 		$34.7K Buy
1,761
+1,726
+4,931% +$27.1K ﹤0.01% 2889
2023
Q1 		$1K Sell
35
-5,421
-99% -$83.7K ﹤0.01% 5546
2022
Q4 		$57K Buy
5,456
+5,449
+77,843% +$48.4K ﹤0.01% 2253
2022
Q3 		$0 Sell
7
-3,570
-100% -$26.9K ﹤0.01% 6220
2022
Q2 		$32K Buy
3,577
+954
+36% +$11.1K ﹤0.01% 3302
2022
Q1 		$47K Buy
2,623
+213
+9% +$6.63K ﹤0.01% 2777
2021
Q4 		$137K Buy
2,410
+2,063
+595% +$138K ﹤0.01% 2032
2021
Q3 		$26K Buy
347
+142
+69% +$15K ﹤0.01% 3479
2021
Q2 		$34K Sell
205
-334
-62% -$58.5K ﹤0.01% 3350
2021
Q1 		$95K Buy
539
+454
+534% +$91.6K ﹤0.01% 2627
2020
Q4 		$17K Sell
85
-88
-51% -$16.3K ﹤0.01% 3960
2020
Q3 		$34K Buy
+173
New +$41.7K ﹤0.01% 3682

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s GOCO Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 6,352 shares — an estimated $9.59K sold.

Tower Research Capital (TRC) first reported a position in GOCO in Q3 2020 and held it in 23 quarters. The position peaked at $137K in Q4 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,352 GoHealth shares in Q2 2026, an estimated $9.59K.
  • Tower Research Capital (TRC) first reported a position in GoHealth in Q3 2020 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s GoHealth position peaked at $137K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.